 SAN MATEO, Calif. and CAMBRIDGE, Mass., June 01, 2022 GLOBE NEWSWIRE -- Kronos Bio, Inc. Nasdaq: KRON, a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today announced that President and Chief Executive Officer Norbert Bischofberger, Ph.D., will participate in fireside chats at the following investor conferences: 